Your browser does not support JavaScript! before use docindia please enable Javascript on your browser

Dr. Ritesh Gupta

Dr. Ritesh Gupta - Internal medicine in Delhi

Dr. Ritesh Gupta

MBBS, MD - General Medicine

Internal medicineInternal medicine
  • Delhi, Delhi
  • 10 Awards

Is this your profile? Need to edit info? Click Here

Clinic Locations

Fortis C-DOC Hospital

B-16, Chirag Enclave, Delhi, Delhi, India,

Services

  • Type 1 Diabetes Treatment
  • Thyroid Disorder Treatment
  • Diabetic foot
  • Insulin Therapy
  • Male Sexual Dysfunction & Hormonal Disorder
  • Insulin Treatment
  • Peritoneal Dialysis
  • Arthritis Management
  • Irritable Bowel Syndrome ( IBS ) Treatment
  • Congenital Disorders Evaluation / Treatment
  • Chickenpox Treatment
  • Bronchial Asthma Treatment
  • Vaccination/ Immunization
  • Infectious Disease Treatment
  • Immunity Therapy
  • Gestational Diabetes Management
  • Joint and Muscle Problems
  • Chronic Kidney Disease ( CKD )
  • Hypertension Treatment
  • Health Checkup (General)
  • Diabetes in Children
  • Diabetes Renal Failure
  • Abdominal Pain Treatment
  • Chronic Pain Treatment
  • bioidentical hormone therapies for men and women
  • Diabetes Management
  • Chronic Obstructive Pulmonary Disease (COPD) Treatment
  • Cough Treatment
  • Tuberculosis (TB) Treatment
  • Type 2 Diabetes Treatment
  • Hypertriglyceridemia
  • Diabetic Ulcer Treatment
  • Dyslipidemia
  • Electrophysiology
  • Emaciation
  • Preoperative treatment
  • Fibromyalgia Treatment
  • Foot infection
  • Former Obese
  • Hormonal therapy
  • Malaria Treatment
  • Peptic / Gastric Ulcer Treatment
  • Jaundice Treatment
  • Plantar Fascitis
  • Gastroenteritis Treatment
  • Migraine Treatment
  • Typhoid Fever Treatment
  • Gout Treatment
  • Anemia Treatment
  • Appendicitis Treatment
  • ENT Checkup (General)
  • Rheumatic Heart Disease Treatment

Education

  • All India Institute of Medical Sciences, New Delhi - 1994 Graduated
    MBBS
  • All India Institute of Medical Sciences, New Delhi - 1998 Graduated
    MD - General Medicine

Work & Experience

  • Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
    Additional Director at Fortis C-DOC
  • Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
    Head Clinical Operations and Senior Consultant
  • Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj
    Consultant in the Department of Diabetes and Metabolic Disease
  • an initiative of Apollo Health and Lifestyle Limited
    Consultant in Internal Medicine at Apollo Clinic
  • Escorts Heart Institute and Research Centre
    Senior Resident in the Department of Cardiology and as Internist
  • All India Institute of Medical Sciences
    Senior Resident (Registrar) in the Department of Medicine

Awards

  • Handa R, Gupta R, Wig N, Agarwal P, Wali JP. Microfilariae of Wuchereria bancrofti in Ascitic Fluid. Indian J Med Sci

  • Gupta R, Prasad HK, Nagarkar KM, Dey AB. Preliminary study on circulating serum levels of tumor necrosis factor-Alpha in patients of tuberculosis. Indian J Clin Biochem

  • Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP; Consensus Group. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian India

  • Gupta R, Misra A. Screening For And Prevention Of Diabetes In India: Need For Simple And Innovative Strategies. Diabetes Technol Ther

  • Subramanian A, Nigam P, Misra A, Pandey Rn, Mathur M, Gupta R, Madhusudan S. Severe Vitamin D Deficiency In Patients With Type 2 Diabetes In North India

  • Co-investigator In The Trial Titled Phase 2, 12 Week Randomized, Double Blind, Parallel Group Placebo-controlled Study To Evaluate Safety, Tolerability, And Efficacy Of Grc 8200, A New Oral Dpp-iv Inhibitor, In Patients With Type 2 Diabe

  • Co-investigator In The Trial Titled Multicenter, Randomized, Double Blind, Placebo-controlled Clinical Trial To Evaluate The Effect Of 52 Weeks Treatment With Vildagliptin On Left Ventricular Function In Patients With Type 2 Diabetes

  • Co-investigator In The Trial Titled Randomized, Double-blind, Placebo- And Sitagliptin-controlled, Multi-center Study To Evaluate Safety And Efficacy Of Dutogliptin In Type 2 Diabetes Mellitus Subjects With Moderate And Severe Renal Impai

  • Co-investigator In The Trial Titled 12- Week Multicenter, Randomized, Double Blind, Placebo-controlled Parallel Group Adaptive Design Study To Evaluate The Efficacy On Blood Glucose Control And Safety Of Five Doses Of Lcq

  • Co-investigator In The Trial Titled Multicentre, Randomized, Double-blind, Placebo-controlled Phase Iv Trial To Evaluate The Effect Of Saxagliptin On The Incidence Of Cardiovascular Death, Myocardial Infarction Or Ischemic Stroke In Patie

questions and answer empty

Get Your Health Questions Answered Online By the Doctor.

Ask Free Question
Is this your profile? Need to edit info? Click Here

Similar Doctors

Share On Social Media

Share this link via